J9207 HCPCS code: Injection, ixabepilone, 1 mg
J9207 is the HCPCS Level II code for injection, ixabepilone, 1 mg. In 2024 Medicare paid an average of $102.85 per service for J9207 across 4,525 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 90 per day on outpatient hospital claims. Medicare volume fell 71% from 2022 to 2024 (15,821 to 4,525 services). In 2024, about 34 clinicians billed Medicare for J9207 for 25 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2009-01-01 |
| Last action effective | 2009-01-01 |
Who bills J9207 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 34 |
| Medicare beneficiaries | 25 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9207, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 15,821 | 69 | $110.11 | $87.89 |
| 2023 | 7,185 | 32 | $119.63 | $95.31 |
| 2024 | 4,525 | 25 | $129.07 | $102.85 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 90 | Clinical: Data |
| practitioner claims | 90 | Clinical: Data |
What changed for J9207
- 2009-01-01: J9207 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9207?
J9207 is the HCPCS Level II code for injection, ixabepilone, 1 mg. Short descriptor: "Ixabepilone injection".
How much does Medicare pay for J9207?
In 2024, the average Medicare payment was $102.85 per service (average allowed $129.07).
Does Medicare cover J9207?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9207 can be billed per day?
90 on outpatient hospital claims; 90 on practitioner claims (NCCI medically unlikely edits).
Related J92 codes
- J9200 — Injection, floxuridine, 500 mg
- J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202 — Goserelin acetate implant, per 3.6 mg
- J9203 — Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204 — Injection, mogamulizumab-kpkc, 1 mg
- J9205 — Injection, irinotecan liposome, 1 mg
- J9206 — Injection, irinotecan, 20 mg
- J9208 — Injection, ifosfamide, 1 gram
- J9209 — Injection, mesna, 200 mg
- J9210 — Injection, emapalumab-lzsg, 1 mg
- J9211 — Injection, idarubicin hydrochloride, 5 mg
- J9212 — Injection, interferon alfacon-1, recombinant, 1 microgram
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9207
- Watch J9207 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9207
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.